Cristina MD - Bergenbio ASA Chief Officer

All Insiders . Norway . 
Stock . Bergenbio ASA . Stakeholders . Insider . Cristina MD
BGBIO Stock  NOK 10.87  0.48  4.23%   

Insider

Cristina MD is Chief Officer of Bergenbio ASA
Phone47 55 96 11 59
Webhttps://www.bergenbio.com

Bergenbio ASA Management Efficiency

The company has return on total asset (ROA) of (0.4939) % which means that it has lost $0.4939 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.9551) %, meaning that it generated substantial loss on money invested by shareholders. Bergenbio ASA's management efficiency ratios could be used to measure how well Bergenbio ASA manages its routine affairs as well as how well it operates its assets and liabilities.
Bergenbio ASA has accumulated 942 K in total debt with debt to equity ratio (D/E) of 0.1, which may suggest the company is not taking enough advantage from borrowing. Bergenbio ASA has a current ratio of 8.07, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Bergenbio ASA until it has trouble settling it off, either with new capital or with free cash flow. So, Bergenbio ASA's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bergenbio ASA sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bergenbio to invest in growth at high rates of return. When we think about Bergenbio ASA's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Erik NyborgAker Horizons AS
N/A
Jan EngebretsenTelenor ASA
75
Alasdair CookEquinor ASA
48
Jorgen TellefsenAker Horizons AS
N/A
Kari BechMoenDnB ASA
42
Lars ThomsenTelenor ASA
51
Nanna TollefsenAker Horizons AS
N/A
Ana NordangEquinor ASA
N/A
Christian YggsethAker Horizons AS
N/A
Signe HelliesenSparebank 1 SR
47
Torbjorn KjusAker ASA
53
Tove AndersonEquinor ASA
N/A
Inge ReinertsenSparebank 1 SR
52
Therese HolmNorsk Hydro ASA
N/A
Trond SoraasSparebank 1 SMN
55
Jorunn LovaasDnB ASA
62
Benedicte FasmerSparebank 1 SR
58
Christina GlennAker ASA
35
Martin HolteAker ASA
44
Tore MedhusSparebank 1 SR
58
Roger AntonesenSparebank 1 SR
48
BerGenBio ASA, a clinical-stage biopharmaceutical company, develops medicines to treat immune evasive, drug resistant, and metastatic cancers. The company was founded in 2007 and is headquartered in Bergen, Norway. BerGenBio ASA is traded on Oslo Stock Exchange in Norway. Bergenbio ASA (BGBIO) is traded on Oslo Stock Exchange in Norway and employs 34 people.

Management Performance

Return On Equity-0.96
Return On Asset-0.49

Bergenbio ASA Leadership Team

Elected by the shareholders, the Bergenbio ASA's board of directors comprises two types of representatives: Bergenbio ASA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bergenbio. The board's role is to monitor Bergenbio ASA's management team and ensure that shareholders' interests are well served. Bergenbio ASA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bergenbio ASA's outside directors are responsible for providing unbiased perspectives on the board's policies.
Rune Skeie, Chief Officer
Debbie Molyneux, Chief Officer
Nigel MSc, Chief Officer
Alison Messom, Director Operations
James Barnes, Chief Officer
Cristina MD, Chief Officer
Martin Olin, Chief Officer
Gayle MBA, Chief Officer
Akil Jackson, Medical Director

Bergenbio Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Bergenbio ASA a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity-0.96
Return On Asset-0.49
Operating Margin(383.14) %
Current Valuation421.26 M
Shares Outstanding88.66 M
Shares Owned By Insiders34.95 %
Shares Owned By Institutions19.17 %
Price To Book3.92 X
Price To Sales756.59 X
Revenue774 K

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Other Information on Investing in Bergenbio Stock

Bergenbio ASA financial ratios help investors to determine whether Bergenbio Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bergenbio with respect to the benefits of owning Bergenbio ASA security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY